Business Services Industry
Statement from Teva Pharmaceuticals USA on Affordable Biologic Pharmaceuticals
Business Wire, June 23, 2007
NORTH WALES, Pa. -- The following statement is released by George Barrett, Chief Executive Officer, Teva North America and Corporate Executive VP, Global Pharmaceutical Markets, Teva Pharmaceutical Industries Ltd.
"We applaud these senators in their effort to create a mission-critical pathway for providing affordable biologic pharmaceuticals to the American consumer. Teva is still in the process of reviewing the details of this proposal; however, we believe that the period of market exclusivity made available to innovators is a high price for the American consumer to pay for this much needed resolution."
COPYRIGHT 2007 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
Most Popular Business Publications
Content provided in partnership with
